Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun-Ichi Iga

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Journal of Psychopharmacology (Oxford, England)|May 6, 2025
Brexpiprazole augmentation and mitochondrial gene expression changes in major depressive disorderKohei Kondo, Yuta Yoshino, Hiroshi Kumon, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Association Study of Fat-mass and Obesity-associated Gene and Body Mass Index in Japanese Patients with Schizophrenia and Healthy SubjectsShin-Ya Watanabe, Jun-Ichi Iga, Shusuke Numata, et al.
Neuropsychiatric Disease and Treatment|March 7, 2017
Gene expression-based biological test for major depressive disorder: an advanced studyShin-Ya Watanabe, Shusuke Numata, Jun-Ichi Iga, et al.
Journal of Affective Disorders|May 26, 2015
Polymorphism in the promoter of the gene for the serotonin transporter affects the age of onset of major depressive disorder in the Japanese populationShin-ya Watanabe, Jun-ichi Iga, Shusuke Numata, et al.
Journal of Psychiatry & Neuroscience : JPN|May 19, 2009
Positive association of the pericentrin (PCNT) gene with major depressive disorder in the Japanese populationShusuke Numata, Jun-Ichi Iga, Masahito Nakataki, et al.
Frontiers in Neuroscience|June 8, 2017
DNA Methylation Changes in Intron 1 of <i>Triggering Receptor Expressed on Myeloid Cell 2</i> in Japanese Schizophrenia SubjectsYuta Yoshino, Yuki Ozaki, Kiyohiro Yamazaki, et al.
Acta Neurologica Scandinavica|October 30, 2019
DRD2 methylation to differentiate dementia with Lewy bodies from Parkinson's diseaseYuki Ozaki, Yuta Yoshino, Kiyohiro Yamazaki, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|August 9, 2017
Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil TreatmentYuta Yoshino, Takaaki Mori, Taku Yoshida, et al.
Neuropsychopharmacology Reports|December 23, 2024
Association Between Stress-Induced Weight Loss and Autophagy-Related Gene Expression in the Hippocampus and Midbrain of Depression Model MiceHiroaki Mori, Yuta Yoshino, Mariko Okano, et al.
BMC Genomics|April 21, 2021
Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey methodYuta Yoshino, Hiroshi Kumon, Takaaki Mori, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Journal of Psychopharmacology (Oxford, England)|May 6, 2025
Brexpiprazole augmentation and mitochondrial gene expression changes in major depressive disorderKohei Kondo, Yuta Yoshino, Hiroshi Kumon, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|February 23, 2013
Association Study of Fat-mass and Obesity-associated Gene and Body Mass Index in Japanese Patients with Schizophrenia and Healthy SubjectsShin-Ya Watanabe, Jun-Ichi Iga, Shusuke Numata, et al.
Neuropsychiatric Disease and Treatment|March 7, 2017
Gene expression-based biological test for major depressive disorder: an advanced studyShin-Ya Watanabe, Shusuke Numata, Jun-Ichi Iga, et al.
Journal of Affective Disorders|May 26, 2015
Polymorphism in the promoter of the gene for the serotonin transporter affects the age of onset of major depressive disorder in the Japanese populationShin-ya Watanabe, Jun-ichi Iga, Shusuke Numata, et al.
Journal of Psychiatry & Neuroscience : JPN|May 19, 2009
Positive association of the pericentrin (PCNT) gene with major depressive disorder in the Japanese populationShusuke Numata, Jun-Ichi Iga, Masahito Nakataki, et al.
Frontiers in Neuroscience|June 8, 2017
DNA Methylation Changes in Intron 1 of <i>Triggering Receptor Expressed on Myeloid Cell 2</i> in Japanese Schizophrenia SubjectsYuta Yoshino, Yuki Ozaki, Kiyohiro Yamazaki, et al.
Acta Neurologica Scandinavica|October 30, 2019
DRD2 methylation to differentiate dementia with Lewy bodies from Parkinson's diseaseYuki Ozaki, Yuta Yoshino, Kiyohiro Yamazaki, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|August 9, 2017
Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil TreatmentYuta Yoshino, Takaaki Mori, Taku Yoshida, et al.
Neuropsychopharmacology Reports|December 23, 2024
Association Between Stress-Induced Weight Loss and Autophagy-Related Gene Expression in the Hippocampus and Midbrain of Depression Model MiceHiroaki Mori, Yuta Yoshino, Mariko Okano, et al.
BMC Genomics|April 21, 2021
Effects of AGXT2 variants on blood pressure and blood sugar among 750 older Japanese subjects recruited by the complete enumeration survey methodYuta Yoshino, Hiroshi Kumon, Takaaki Mori, et al.
Pageof 13